To date, the U.S. Marine Shrimp Farming Program has:

1. established the world's first captive populations of high health shrimp stocks and the world's first breeding and genetic selection program for marine shrimp;
2. completed pioneering research and development in advanced molecular diagnostic tools for disease screening and control;
3. described the etiology of shrimp diseases associated with viral pathogens;
4. supported members of the U.S. American Processors Association in protecting receiving waters from the introduction of viral pathogens;
5. played a lead role in the Joint Subcommittee on Aquaculture's efforts to assess the threat of foreign viral pathogens;
6. supplied the U.S. industry with genetically improved and disease resistant shrimp stocks;
7. developed high technology biosecure shrimp production systems to protect both cultured and wild stocks from disease, and,
8. developed new feed formulations to minimize waste generation.

These accomplishments are encouraging. The advances in these fundamental areas have provided the foundation for achieving the overall goal. The Consortium is in the process of integrating these advances into practical shrimp farming systems. USMSFP remains the only full service shrimp breeding and disease diagnostic program, supporting both industry and research.